|
Amador Bioscience is a translational & clinical CRO providing global-standard quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research and regulatory filing services to clients ranging from cutting-edge biotech startups to industry-leading multinationals in the US, Europe and China.
Booth #: 1
|
|
AMR-Knoxville (formerly NOCCR) is a multispecialty clinical research center within Alliance for Multispecialty Research (AMR). AMR-Knoxville is a fully-equipped Phase I Unit with 60 beds and 24,500+ sq ft of space located within the Univ of Tennessee Medical Ctr. This unit excels at First-in-Human, procedurally-complex trials and special populations. The primary Principal Investigator, William B. Smith, MD, has been conducting clinical research for 35+ years and has conducted over 2,000 trials.
Booth #: 15
|
|
.png)
|
BioPharma Services Inc is a client-focused, Contract Research Organization specializing in Phase I/IIa Clinical Trials, Bioequivalence Studies and Bioanalysis, serving pharmaceutical, medical device and biotechnology companies globally. Our headquarters are located in Toronto, Ontario, Canada, with a 180-bed clinical facility including a 14-bed Phase I unit and a 120-bed clinical facility in St Louis, Missouri. BioPharma has been inspected by US FDA, Health Canada, EMA (ANSM & DKMA), UK MHRA and ANVISA.
Booth #:2
|
|
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.
Contact us at [email protected]
Booth #: 10
|
|
CTI is a global, privately held, full-service research service provider delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. In addition to traditional CRO services, CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials and state-of-the-art laboratory services. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com
Booth #: 7
|
.png)
|
Gilead Sciences Inc is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Booth #: 9
|
|
GSK is a science-led global healthcare company with a special purpose to improve the quality of human life by helping people do more, feel better, live longer. We help improve the health of people around the world by discovering, developing and manufacturing innovative medicines, vaccines and consumer healthcare products. We are building a stronger purpose and performance culture underpinned by our values and expectations so that together we can deliver extraordinary impact for patients and consumers and make GSK a brilliant place to work.
Our values are Patient focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.
Contact: Mindy Magee (484-995-2756)
Booth #: 13
|
.png)
|
HepQuant's tests are in use by major pharmaceutical companies in clinical trials under FDA-issued Investigational Device Exemptions (IDEs). HepQuant testing provides a Disease Severity Index (DSI) and SHUNT fraction (SHUNT) scores which may noninvasively quantify liver function and portal-systemic shunting. HepQuant has completed 2000+ test in over 1000+ subjects through 30+ clinical trials completed and ongoing. Recently, HepQuant completed a Hepatic Impairment study with Theravance and the data is being presented at this meeting.
Contact us at (303) 923-2103.
Booth #: 8
|
|
About the Janssen Pharmaceutical Companies of Johnson & Johnson: At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology and Pulmonary Hypertension.
Learn more at www.janssen.com. Follow us at www.twitter.com/JanssenGlobal.
Booth #: 11
|
|
Metrum Research Group is the leading innovator in biomedical modeling & simulation. We have provided strategic decision making with the highest quality of scientific expertise for 150+ companies on over 550 projects. Visit our Exhibit booth to learn about how we aim to defeat disease by taking a quantitative approach to drug development. Ask about job openings including Modeling & Simulation Scientist and Clinical Pharmacologist positions.
Booth #: 5
|
|
Patel Kwan Consultancy LLC provides clinical pharmacology, pharmacokinetics and pharmacometrics services. PK team members on average have greater than 20 years’ experience working at CROs, industry, regulatory agencies, and academia. Patel Kwan provides clinical pharmacology support including gap analyses of drug development programs, non-compartmental pharmacokinetic analysis and reporting, regulatory writing and bioanalytical support. Meet us at our booth to hear more about how Patel Kwan can support your drug development needs.
|
|
Pumas-AI was founded by Dr. Joga Gobburu and Dr. Vijay Ivaturi, driven by a team of scientists at the Univ of Maryland in partnership with scientific computing experts. The solutions offered at Pumas-AI are fine-tuned to the needs of healthcare research, regulation and delivery, with a central vision to double pharmaceutical and patient care success by democratizing tools and education in the healthcare data analytics space. With a focused goal on providing better solutions for patient care, be it via pharmaceutical drug development innovation or tools for point of care, Pumas-AI aims to bring value, innovation and efficiency to healthcare.
Booth #: 6
|
|
Redbock is a consultancy that delivers highly specialized resourcing solutions for the pharmaceutical, biotechnology and medical device industries. Our primary areas of expertise include: Clinical Pharmacology, Clinical Operations, Biometrics, Engineering and Quality & Regulatory.
Booth #: 17
|
|
SecureGen is a Scientific Platform and Information Technology Service provider to Pharmaceutical, Biotechnology and Healthcare organizations with a core focus on accelerating drug development innovation by providing a secure Platform as a Service for management of regulatory compliant data, analysis and tools. SecureGen drug development cloud is a fully managed and validated solutions supporting biostatistics, data science, clinical pharmacology, pharmacometrics, model-based meta-analysis, quantitative systems pharmacology, physiologically based pharmacokinetic and pharmacogenomics.
Contact us at [email protected].
Booth #: 14
|
|
Simulations Plus Inc is a premier developer of modeling and simulation software and consulting services supporting drug discovery, development, research and regulatory submissions. We partner with companies to provide a strategic, data-driven modeling methodology, starting in early discovery, continuing through preclinical/clinical development and clinical trials/post approval. We offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, DILIsym®, NAFLDsym®, MonolixSuite® and more) to bridge data mining and compound library screening with QSAR models, PK/PD model development and PBPK/TK modeling & simulation in animals and humans following administration around the body and quantitative systems pharmacology approaches. Our technology and consulting services are utilized by major pharmaceutical, biotechnology and regulatory agencies worldwide.
Contact us at [email protected].
Booth #: 12
|
|
TNO will exhibit the latest developments in the use of microtracer-labeled drugs in clinical pharmacology. TNO's microtracer technology can deliver simultaneous MIST and Mass Balance data that enables companies to directly identify human metabolites in the development process (Phase 1). With TNO's microtracer expertise, drug development becomes a streamlined and targeted process. Besides we will showcase in vitro and ex vivo platforms to investigate intestinal permeability, microbiome induced metabolism and biliary excretion/DDIs/hepatic clearance.
Contact: [email protected]
Booth #: 4
|
|
XYZAGEN is a North Carolina based hybrid, client focused, drug development consulting and contract research organization. We’re leading experts in First-in-Rat® and First-in-Mouse® PK studies and have experience in incorporating safety assessments into PK studies to provide that initial assessment of PK, Safety and Tolerability that is typically done in First-in-Human PK studies. Our contract research business incorporates a rodent focused vivarium and mass spectrometry lab to support your in vivo PK project. Our consults are experts in clinical pharmacology drug development, study design and analysis. We have worked with midsized pharma to early SBIR/STTR funded biotechs.
Contact us at (919) 726-2072.
Booth #: 16
|